Amarin Corp plc (ADR) (NASDAQ:AMRN)

Major Biopharma Catalysts on the December FDA Calendar

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Markets have hit new highs recently, but the main indexes were all marginally lower on Wednesday morning. With the Dow Jones industrials up over 28,000 and the S&P 500 over ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amarin, BofA, Citi, JPMorgan, Liberty SiriusXM, Microsoft, Tesla, TripAdvisor, Twitter, Workday and More

Stocks hit new highs on Friday with the Dow Jones industrials closing above 28,000 for the first time and with the S&P 500 up over 3,100, but stocks were looking ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AECOM, Arconic, Bed Bath & Beyond, Dollar General, eBay, Grubhub, Lowe’s, 3M, Nvidia, Stitch Fix and More

Stocks were indicated to open higher on Tuesday as bank and other earnings look stronger than anticipated. The reports that China wants more talks before signing the phase one deal ...
Read Full Story »

Is Amarin’s Cardio Trial in Trouble?

Amarin Corp. PLC (NASDAQ: AMRN) shares dropped on Friday after the firm announced that it received notice from the U.S. Food and Drug Administration (FDA). According to the notice, the ...
Read Full Story »

9 After-Hours Stock Movers Tanking After Big News Reactions

The Dow Jones industrial average closed at 27,219.85 after a 115.78 drop on the day, and the S&P 500 closed down almost 20 points at 2,984.42. While earnings season is ...
Read Full Story »

Tuesday’s Biggest Biotech Movers

Despite this truncated trading week, Tuesday was a breakout day for a few biotech companies. In this case, all these companies saw a solid gain. With the markets back near ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Amarin, Apple, AutoNation, BlackRock, E*Trade, Etsy, Kellogg, PG&E and More

Stocks were indicated to open marginally higher on Wednesday, but this is a day after the gap-up open failed to hold by the end of Tuesday and after a 602 ...
Read Full Story »

Why Amarin Shares Are Exploding

Amarin Corp. PLC (NASDAQ: AMRN) shares absolutely skyrocketed on Monday after the company announced top-line results from the Vascepa cardiovascular (CV) outcomes trial, REDUCE-IT. Needless to say, the results were ...
Read Full Story »

Helios and Matheson, Tyson Foods Wallow in Monday’s 52-Week Low Club

July 30, 2018: Here are four stocks trading with heavy volume among 133 equities making new 52-week lows in Monday's session. On the NYSE decliners led advancers by about 1.14 ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amarin, Amex, Barrick Gold, Cameco, Groupon, ImmunoGen, JPMorgan, Whole Foods and More

Stocks were indicated to open marginally higher on Thursday after a solid rally on Wednesday. Even though this bull market is well over eight years old, equity investors keep finding ...
Read Full Story »
upside

10 Analyst Stocks Under $10 With Massive Upside Projections

Stocks have seen wishy-washy trading of late, and the daily and weekly direction of the market may be less clear until after the elections. Still, it seems like this bull market is ...
Read Full Story »
approve disapprove

Top Analyst Upgrades and Downgrades: DuPont, GoDaddy, Intel, Pandora, Wells Fargo, Western Refining and More

Stocks were marginally higher on Wednesday morning, after Tuesday's 75-point Dow and 13-point S&P 500 gains. Earnings season has begun and things are looking moderately higher. The trends of high valuations ...
Read Full Story »
FDA_logo

8 Major FDA Decisions and Trial Results to Watch for in September

Pharmaceutical and biotech companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount to a great amount ...
Read Full Story »
biotech word cloud

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

Investors have had a hard time in May. Biotech investors also have faced some hard decisions going into the 2016 elections, where both sides of the aisle seem more than willing ...
Read Full Story »